Science Explorer Back to mapMap
Discussion
Researcher · Chinese Academy of Medical Sciences & Peking Union Medical College · China

Mingxia Jiang

Mingxia Jiang publishes mostly in Oncology, Molecular Biology and Biomedical Engineering, on topics such as Nanoplatforms for cancer theranostics, HER2/EGFR in Cancer Research and Inflammasome and immune disorders.

ORCID 0009-0008-6325-4477 OpenAlex
World rank
#1,339,597
of 7,710,434 ranked researchers
Rank in China
#196,901
of 978,568
Works
80
Citations
2.2k
Citations per work
27.4
h-index
20
i10-index 30Top 23% in Oncology
Mingxia Jiang

What does Mingxia Jiang research?

Mingxia Jiang's work is mostly in Medicine (22%), Engineering (15%), Biochemistry, Genetics and Molecular Biology (12%).

Everything else: 36 works · 44.4% of their workHealth Sciences: 18 works · 22.2% of their workMedicine: 18 works · 22.2% of their workOncology: 11 works · 14.0% of their workPulmonary and Respiratory Medicine: 7 works · 8.2% of their workLife Sciences: 15 works · 18.4% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 12.1% of their workMolecular Biology: 10 works · 12.1% of their workImmunology and Microbiology: 5 works · 6.3% of their workImmunology: 5 works · 6.3% of their workPhysical Sciences: 12 works · 15.0% of their workEngineering: 12 works · 15.0% of their workBiomedical Engineering: 7 works · 8.7% of their workElectrical and Electronic Engineering: 5 works · 6.3% of their workTHEIR WORKMingxia Jiang80works
Life Sciences18%Physical Sciences15%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else3644.4%
    1. Medicine1822.2%
    1. Biochemistry, Genetics and Molecular Biology1012.1%
    2. Immunology and Microbiology56.3%
    1. Engineering1215.0%
  1. 1Oncology14% of their works
  2. 2Molecular Biology12% of their works
  3. 3Biomedical Engineering9% of their works
  4. 4Pulmonary and Respiratory Medicine8% of their works
  5. 5Immunology6% of their works
  6. 6Electrical and Electronic Engineering6% of their works

Research topics

Which keywords describe Mingxia Jiang's research?

The keywords of their largest research topics: Nanoparticles, Photothermal Therapy, Breast Cancer, HER2, Chemotherapy-Induced Peripheral Neuropathy, Immune Checkpoint Blockade, Inflammasome and NLRP3.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Nanoparticles111 topic
  2. Photothermal Therapy111 topic
  3. Breast Cancer101 topic
  4. HER2101 topic
  5. Chemotherapy-Induced Peripheral Neuropathy61 topic
  6. Immune Checkpoint Blockade61 topic
  7. Inflammasome61 topic
  8. NLRP361 topic
  9. PD-1 and PD-L161 topic
  10. Taxanes61 topic
  11. Breast Tumours51 topic
  12. Dendritic Cells51 topic
  13. Gene Expression51 topic
  14. Immunity51 topic
  15. Mycobacterium avium51 topic
  16. Nontuberculous Mycobacteria51 topic

Where does Mingxia Jiang work?

Mingxia Jiang's main affiliation in the publication record is Chinese Academy of Medical Sciences & Peking Union Medical College, China.

How many publications and citations does Mingxia Jiang have?

OpenAlex counts 80 works and 2,188 citations for Mingxia Jiang, an h-index of 20, ranking #1,339,597 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Mingxia Jiang

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mingxia Jiang. Posts are plain text and can be reported.